The Effect of Supportive Nursing Instructions on Recurrence of Vulvovaginal Candidiasis Infection during Pregnancy

Eman Mohammed Eraky^1,

¹Department of Maternal & Newborn Health Nursing, Faculty of Nursing, Cairo University, Cairo, Egypt

Cite this paper:
Eman Mohammed Eraky. The Effect of Supportive Nursing Instructions on Recurrence of Vulvovaginal Candidiasis Infection during Pregnancy. American Journal of Nursing Research. 2018; 6(6):437-445. doi: 10.12691/ajnr-6-6-11

Abstract

Pregnant women are more vulnerable to VVC than healthy women with chronic recurrent candidiasis [1]. Supportive nursing instruction help pregnant women in improving their health by adopting preventive measures that help in reducing the incidence and avoid complication from VVC [2,3]. The aim of this quasi-experimental study was to examine the effect of supportive nursing instructions on recurrence of vulvovaginal candidiasis infection during pregnancy. A total of 100 pregnant women diagnosed as having vulvovaginal candidiasis infection who attend antenatal unit at El-Manial maternity hospital in Cairo, Egypt, were recruited for this study. The required data was collected through Semi-structured Interview questionnaire, pre-posttest questionnaire and VVC Follow-up Sheet. Results indicated that the age of the sample range was 18-45 year with a mean of 26.38± 6.56 years old, 64% living in urban area, 74% of the sample was negative smokers, 70% of the sample was housewife &48% of the sample had primary education. The results also revealed that a highly statistically significant difference between mean knowledge score regarding VVC during pregnancy in pretest and posttest (p<0.0001) and a highly statistically significant difference between level of knowledge regarding VVC during pregnancy in pre and posttest as (p<0.0001). Also, there was an observed relieve in majority of the symptoms of VVC infection after four weeks follow-up. In relation to recurrence of vulvovaginal candidiasis symptoms during pregnancy, the results revealed that most of cases did not develop recurrent episode of VVC attack during pregnancy through follow-up till term while minority of cases developed recurrent episode especially in third trimester of pregnancy.

Keywords:
supportive nursing instruction recurrence of VVC during pregnancy

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Mitchell, H. (2004). ABC of sexually transmitted infections/vaginal discharge causes, diagnosis and treatment. J. BMJ, publishing Group Ltd.: 328 (7451) 1306-1308.
[2]	Kamath, p., Pais, M., ayak, M. & Pramila, S. (2014). An awareness program on prevention of vaginalcandidiasis among pregnant women. Nitte University Journal of Health Science. 4(2) 2249-7110.
[3]	Gurewitsch, E.D. (2008). Guide to vaginal infections. BMJ. (333): 849-851. Available at: http://www.vaginalinfection.com/guide-to-vaginal-infection.htmpeople.
[4]	Centers for Disease Control & Prevention (CDC). (2012). vaginal yeast infections fact sheet. Available at: http://www.cdc.gov/ncidod/dbmd/diseaseinfect/Candiasisgen g.htm.
[5]	Johnson, S. R. And Griffiths, H. (2010). Attitudes and experience of women to common vaginal infections. Journal of lower genital tract disinfection. 14 (4): 287-94.
[6]	Namkinga, L.A. (2005). The cross-sectional study on prevalence and risk factors for vaginal candidiasis among female seeking primary health care. East African Medical Journal.82 (3):139-44.
[7]	Baraia, Z.A.A. (2014). Health behaviors for vaginal infection among married women in Ismailia city Master Thesis in Nursing, Faculty of nursing Suez Canal University; Egypt.
[8]	Goncalves, B., Ferreira, C., Alves, C.T., Henriques, M., Azeredo, J. and Silva, S. (2016). Vulvovaginal candidiasis: epidemiology, microbiology and risk factors. Critical Reviews in Microbiology. 42:905-927.
[9]	Leli, C., Mencacci, A., Meucci, M., Bietolini, C., Vitalli, M. and Farinelli, S. (2013). Association of pregnancy and Candida vaginal colonization in women with or without symptoms of vulvovaginitis. Minerva Ginecol.65: 303-309.
[10]	Akah, P.A., Nnamani, C.E. and Nnamani, P.O. (2010). Prevalence and treatment outcome of vulvovaginal candidiasis in pregnancy in a rural community in Enugu State, Nigeria. Journal of Medicine and Medical Sciences. 1(10): 447-452.
[11]	Akinbiyi, A.A., Watson, R. and Feyi-Waboso, P.(2008). Prevalence of Candida albicans and bacterial vaginosis in asymptomatic pregnant women in South Yorkshire, United Kingdom. Outcome of a prospective study. NCBI, Gynecol Obstet. 278(5):463-466.
[12]	Ilkit, M. and Guzel, A.B. (2011). The epidemiology, pathogenesis, and diagnosis of vulvovaginal candidiasis: a mycological perspective. Critical Reviews in Microbiology.37:250–261.
[13]	Spacek, J., Buchta, V., Jılek, P. and Forstl, M. (2007). Clinical aspects and luteal phase assessment in patients with recurrent vulvovaginal candidiasis. European Journal of Obstetrics & Gynecology and Reproductive Biology. 131(2): 198-202.
[14]	Sobel, J.D. (2007).Vulvovaginal candidosis. Lancet.369: 1961-71.
[15]	Dekel, N., Gnainsky, Y., Granot, I. and Mor, G. (2010) Inflammation and implantation. American Journal of Reproductive Immunology. 63: 17-21.
[16]	Roberts, C.L., Rickard, K., Kotsiou, G. and Morris, J.M. (2011). Treatment of asymptomatic vaginal candidiasis in pregnancy to prevent preterm birth: an open label pilot randomized controlled trial. BMC Pregnancy Childbirth. 11: 18.
[17]	Bean, L.M., Jackson, J.R., Dobak, W.J., Beiswenger, T.R. and Thorp, J.A. (2013). Intra-amniotic fluconazole therapy for Candida albicans intra-amniotic infection. Obstetric Gynecology. 121: 452-454.
[18]	Darmstadt, G.L., Dinulos, J.G. and Miller, Z. (2000). Congenital cutaneous candidiasis: clinical presentation, pathogenesis, and management guidelines. Pediatrics. 105(2): 438.
[19]	Aubyn, G.B. and Tagoe, D.N.A. (2013). Prevalence of vaginal infections and associated lifestyles of students in the University of Cape Coast, Ghana.Asian Pacific journal of tropical disease. (3): 267-270. Available at: http://www.ncbi.nlm.nih.gov.
[20]	Jombo, G.T.A., Akpera, M.T., Hemba, S.M. and Eyong, K.I. (2011). Symptomatic vulvovaginal candidiasis: knowledge, perceptions and treatment modalities among pregnant women of an urban settlement in West Africa. African Journal of Clinical and Experimental Microbiology.
[21]	Fardiazar, Z., Ronaci, F., Torab, R. and Goldust, M. (2012). Vulvovaginal candidiasis recurrence during pregnancy. PakistanJournal of Biological Sciences. 15(8): 399-402.
[22]	Ekpenyong, C.E., Inyang-etoh, E. C., Ettebong, E. O., Akpan, U. P., Ibu, J. O. and Daniel, N. E. (2012). Recurrent vulvovaginal candidiasis among young women in south eastern Nigeria: the role of lifestyle and health-care practices. International journal of STD & AIDS.
[23]	Holland, J., Young, M. L., Lee, O. and Chen, S. C. A. (2003). Vulvovaginal carriage of yeasts other than Candida albicans. Sexually Transmitted Infections journal. 79 (3): 249-250.
[24]	Nyirjesy, P., Zhao, Y., Ways, K. and Usiskin, K. (2012). Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor. Current Medical Research and Opinion. 28(7): 1173-1178.
[25]	Ogouyèmi-Hounto, A., Adisso, S. and Djamal, J. (2014). Place of vulvovaginal candidiasis in the lower genital tract infections and associated risk factors among women in Benin. Journal de Mycologie Médicale. 24 (2): 100-105.
[26]	D'Antuono, A., Baldi, E., Bellavista, S., Banzola, N., Zauli, S. and Patrizi, A. (2012). Use of Dermasilk briefs in recurrent vulvovaginal candidosis: Safety and effectiveness. Mycoses. 55(3): 85-89.
[27]	Na, D., Weiping, L., Enfeng, Z., Chan, W., Zhaozhao, X. and Honghui, Z. (2014). Risk factors for candida infection of the genital tract in the tropics. African Health Sciences journal. 14(4).
[28]	Jaeger, M., Plantinga, T.S., Joosten, L.A., Kullberg, B. and Netea, M. (2013). Genetic basis for recurrent vulvo-vaginal candidiasis. Current Infectious Disease Reports. 15(2):136-142.